0.9250
0.0000
(0.00%)
At close: January 10 at 3:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-21,219.3000
-21,225.3000
-23,745.9000
-20,321.5000
-6,126.6000
Investing Cash Flow
-446.6000
-206.6000
-4,865.5000
-1,810.8000
-1,457.6000
Financing Cash Flow
20,341.7000
23,990.7000
3,902.7000
37,335.7000
15,805.6000
End Cash Position
3,055.8000
3,204.0000
645.2000
25,353.9000
10,150.5000
Interest Paid Supplemental Data
30.4000
56.4000
12.2000
12.2000
3.1000
Capital Expenditure
-446.6000
-206.6000
-4,880.5000
-1,894.8000
-1,457.6000
Issuance of Capital Stock
0.1000
659.1000
--
40,000.0000
18,000.0000
Issuance of Debt
20,800.0000
24,000.0000
4,610.7000
665.9000
656.1000
Repayment of Debt
-457.2000
-557.2000
-508.0000
-573.7000
-188.1000
Free Cash Flow
-21,665.9000
-21,431.9000
-28,626.4000
-22,216.3000
-7,584.2000
12/31/2020 - 10/16/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SBMFF Sino Biopharmaceutical Limited
0.4110
0.00%
ESLAW Estrella Immunopharma, Inc.
0.0910
-0.11%
ATNFW 180 Life Sciences Corp.
0.0100
-4.76%
IMTXW Immatics N.V.
0.0900
-43.75%
INTI Inhibitor Therapeutics, Inc.
0.0670
+13.56%
REVBW Revelation Biosciences, Inc.
0.0140
+7.69%
MBXBF Microbix Biosystems Inc.
0.2980
+1.71%
WSNAF Wesana Health Holdings Inc.
0.0055
+103.70%
SRZNW Surrozen, Inc.
0.0500
0.00%
AURX Nuo Therapeutics, Inc.
1.5225
+8.75%